These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23863902)

  • 1. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
    Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
    J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses.
    Cello J; Strannegård O; Svennerholm B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2097-108. PubMed ID: 8811009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.
    Wei R; Yang C; Zeng M; Terry F; Zhu K; Yang C; Altmeyer R; Martin W; De Groot AS; Leng Q
    PLoS One; 2012; 7(12):e51957. PubMed ID: 23251663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
    Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
    Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
    Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
    Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016.
    Wang J; Teng Z; Cui X; Li C; Pan H; Zheng Y; Mao S; Yang Y; Wu L; Guo X; Zhang X; Zhu Y
    Emerg Microbes Infect; 2018 Jan; 7(1):8. PubMed ID: 29362406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls.
    Dang S; Gao N; Li Y; Li M; Wang X; Jia X; Zhai S; Zhang X; Liu J; Deng H; Dong T
    Immunology; 2014 May; 142(1):89-100. PubMed ID: 24329688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
    Wu TC; Wang YF; Lee YP; Wang JR; Liu CC; Wang SM; Lei HY; Su IJ; Yu CK
    J Virol; 2007 Oct; 81(19):10310-5. PubMed ID: 17626076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.
    Mao QY; Liao XY; Yu X; Li N; Zhu FC; Zeng Y; Liang ZL; Li FX; Wang JZ; Lu FM; Zhuang H
    Chin Med J (Engl); 2010 Jul; 123(13):1679-84. PubMed ID: 20819628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
    Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
    Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
    Maje Bello A; Chaimongkolnukul K; Poomputsa K; Mekvichitsaeng P; Maprang Roshorm Y
    Vaccine; 2024 Jun; 42(17):3733-3743. PubMed ID: 38705805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
    Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
    Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
    Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
    Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16.
    Zhang X; Sun C; Xiao X; Pang L; Shen S; Zhang J; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    Jpn J Infect Dis; 2016; 69(1):66-74. PubMed ID: 26073737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.